Low-Dose Omega-3 Fatty Acid and Vitamin D for Anthropometric, Biochemical Blood Indices and Respiratory Function. Does it work?

Abstract

Omega-3 fatty acids and vitamin D3 have beneficial effects on different blood, cardiovascular parameters and physical performance. However, the effect of low-dose omega-3 fatty acid supplementation remains unclear. 84 office workers aged 40-60years, participated in a 16-week open, randomized, placebo-controlled, parallel-group study. The experimental group received 330mg of omega-3 fatty acid and 0.005mg (200IU) of vitamin D3 per day and the control group received placebo. Anthropometric, biochemical blood and respiratory indices were measured at 12 and 16 weeks. Body mass (BM) and body mass index (BMI) significantly reduced in both the experimental (BM from 74.4±13.04 to 73.2±13.02kg, p<0.001; BMI from 25.8±4.1 to 25.4±4.3kg/m2, p<0.001) and the placebo groups (BM from 69.5±11. to 68.7±11.4kg, p<0.05; BMI from 24.1±4.0 to 23.8±4.2kg/m2, p<0.05). Omega-3 fatty acid supplementation significantly improved glucose (from 5.12±0.55 to 4.97±0.62mmol/l; p=0.05), total cholesterol (from 5.86±1.0 to 5.32±1.55mmol/l; p=0.003), and vitamin D levels (from 35.07±21.65 to 68.63±25.94nmol/l; p=0.000). Maximal oxygen consumption (from 33.7±2.4 to 36.6±3.2ml/kg/min, p=0.035), forced vital capacity (from 3.5±0.6 to 3.9±0.9l, p=0.044), forced expiratory volume (from 3.2±0.6 to 3.5±0.7l, p=0.014), and peak expiratory flow (from 6.7±1.4 to 7.5±1.6l/s, p=0.019) also slightly improved in the omega-3 fatty acid group. Daily supplementation of 330mg of omega-3 fatty acids had a slight positive impact on total cholesterol and glucose level, while there was no effect on low and high density lipoproteins, and triglycerides levels. Therefore, dose of 330mg per day seems as insufficient.